← USPTO Trademark Applications

ADAPTIMMUNE TRANSFORMING T CELL THERAPY

Status Change TM79178123 Kind: other Mar 21, 2026

Abstract

Medical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient; Pharmaceutical preparations for the treatment of cancer and autoimmune diseases via T cell therapy

Filing Date

2015-10-14